Congress : SABCS
Authors : Audrey Monneur, François Bertucci, Audrey Lardy-Cleaud , et al.
Experts group or program : ESMÉ - données de vie réelle en cancérologie
Primary inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer. Survival of IBC patients has been improved by multimodal therapy. However 5-year overall survival (OS) still remains close to 50-60%, due to high risk of disseminated disease. Given the low incidence, prognosis of metastatic cases stages is poorly described.
